Leslie J. Padrnos, M.D.

  1. Houghton DE, Casanegra AI, Wysokinski WE, Padrnos LJ, Wysokinska E, Pruthi R, Heaton H, Sridharan M, McBane RD, Shah S. COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds. Thromb Res 2024 Mar; 235:8-10 Epub 2024 Jan 12
    View PubMed
  2. Williams LA 3rd, Adamski J, Kinard TN, Ertz-Archambault NM, Lu Q, Gray K, Herrick JL, Su L, Padrnos L. The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia. J Clin Apher. 2023 Dec; 38 (6):755-759 Epub 2023 Sept 04
    View PubMed
  3. Riaz IB, Fuentes H, Deng Y, Naqvi SAA, Yao X, Sangaralingham LR, Houghton DE, Padrnos LJ, Shamoun FE, Wysokinski WE, McBane RD 2nd. Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis. JAMA Netw Open. 2023 Jul 3; 6 (7):e2325283 Epub 2023 July 03
    View PubMed
  4. Houghton DE, Wysokinski WE, Padrnos LJ, Shah S, Wysokinska E, Pruthi R, Ghorbanzadeh A, Ashrani A, Sridharan M, McBane RD, Padmanabhan A, Casanegra AI. Venous thromboembolism after COVID-19 vaccination in patients with thrombophilia. Am J Hematol. 2023 Apr; 98 (4):566-570 Epub 2023 Jan 28
    View PubMed
  5. Abdou MM, Forey KP 2nd, Padrnos L. 24-Year-Old Woman With Menorrhagia, Mucosal Bleeding, and Easy Bruising. Mayo Clin Proc. 2022 Jul; 97 (7):1375-1379
    View PubMed
  6. Houghton DE, Wysokinski W, Casanegra AI, Padrnos LJ, Shah S, Wysokinska E, Pruthi R, Ashrani A, Sridharan M, Baumann-Kreuziger L, McBane R, Padmanabhan A. Risk of venous thromboembolism after COVID-19 vaccination. J Thromb Haemost. 2022 Jul; 20 (7):1638-1644 Epub 2022 Apr 20
    View PubMed
  7. Shah S, Padrnos L. Complications of Autoimmune Hemolytic Anemia. Hematol Oncol Clin North Am. 2022 Apr; 36 (2):353-363 Epub 2022 Mar 11
    View PubMed
  8. Riaz IB, Fuentes HE, Naqvi SAA, He H, Sipra QR, Tafur AJ, Padranos L, Wysokinski WE, Marshall AL, Vandvik PO, Montori V, Bryce AH, Liu H, Badgett RG, Murad MH, McBane RD 2nd. Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis. Mayo Clin Proc. 2022 Feb; 97 (2):308-324 Epub 2021 June 22
    View PubMed
  9. Francisco MT, Kaufman AE, Northfelt D, Padrnos L, Rosenthal AC, Andres J, Adamski J, Kinard T, Camoriano J. Relapsed refractory acquired thrombotic thrombocytopenic purpura (attp) following COVID-19 vaccination. Blood. 2021; 138(Suppl 1):4218.
  10. Francisco MT, Arana Yi C, Padrnos L, Braga S, Adamski J. Therapeutic plasma exchange for apixaban removal in the setting of delayed clearance and life-threatening bleeding. Blood. 2021; 138(Suppl 1):4271.
  11. Pasha AK, McBane RD, Chaudhary R, Padrnos LJ, Wysokinska E, Pruthi R, Ashrani A, Daniels P, Sridharan M, Wysokinski WE, Houghton DE. Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19. Thromb Res. 2021 Nov; 207:150-157 Epub 2021 Oct 07
    View PubMed
  12. Chaudhary R, Padrnos L, Wysokinska E, Pruthi R, Misra S, Sridharan M, Wysokinski W, McBane RD 2nd, Houghton DE. Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients. Mayo Clin Proc. 2021 Jul; 96 (7):1718-1726 Epub 2021 May 04
    View PubMed
  13. Padrnos LJ, Houghton OM, Iacob CE, Kurli M, Ocal IT, Bryce AH. Genomic profiling proves metastasis of cutaneous melanoma to vitreal fluid. Melanoma Res. 2020 Dec; 30 (6):590-593
    View PubMed
  14. McBane RD 2nd, Torres Roldan VD, Niven AS, Pruthi RK, Franco PM, Linderbaum JA, Casanegra AI, Oyen LJ, Houghton DE, Marshall AL, Ou NN, Siegel JL, Wysokinski WE, Padrnos LJ, Rivera CE, Flo GL, Shamoun FE, Silvers SM, Nayfeh T, Urtecho M, Shah S, Benkhadra R, Saadi SM, Firwana M, Jawaid T, Amin M, Prokop LJ, Murad MH. Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic. Mayo Clin Proc. 2020 Nov; 95 (11):2467-2486 Epub 2020 Aug 31
    View PubMed
  15. Padrnos L, Scherber R, Geyer H, Langlais BT, Dueck AC, Kosiorek HE, Senyak Z, Clark M, Boxer M, Cotter M, Harrison C, Stonnington C, Geda Y, Mesa R. Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition. Cancer Med. 2020 Nov; 9(22):8301-8309. Epub 2020 Sep 25.
    View PubMed
  16. Gonzalez-Velez M, Mead-Harvey C, Kosiorek HE, Kusne YN, Rivera C, Bojanini L, Northfelt DW, Padrnos LJ. Racial/ethnic differences in patients with anemia and folate deficiency. Int J Lab Hematol. 2020 Aug; 42 (4):403-410 Epub 2020 Apr 16
    View PubMed
  17. Padrnos L, Mesa R. Novel agents for the treatment of polycythemia vera: an insight into preclinical research and early phase clinical trials. Expert Opin Investig Drugs. 2020 Aug; 29 (8):809-817 Epub 2020 July 16
    View PubMed
  18. J Padrnos L, Garcia D. May-Thurner syndrome and thrombosis: A systematic review of antithrombotic use after endovascular stent placement. Res Pract Thromb Haemost. 2019 Jan; 3 (1):70-78 Epub 2018 Oct 19
    View PubMed
  19. Padrnos L, Ernst B, Dueck AC, Kosiorek HE, Ginos BF, Toro A, Johnston PB, Habermann TM, Leis JF, Mikhael JR, Nowakowski GS, Colgan J, Porrata L, Ansell SM, Witzig TE, Reeder C. A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma. Clin Lymphoma Myeloma Leuk. 2018 Oct; 18 (10):664-672.e2 Epub 2018 June 15
    View PubMed
  20. Padrnos L, Bennett R, Kosiorek H, Dueck AC, Northfelt D, Mikhael J, Tibes R, Khera N, Mesa RA. Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit. J Cancer Educ. 2018 Jun; 33 (3):653-659
    View PubMed
  21. Padrnos L, Mesa RA. Myeloproliferative Neoplasms: Translating New Discoveries Into Better Outcomes, Better Quality of Life. Oncology (Williston Park). 2017 Jul 15; 31 (7):521-9
    View PubMed
  22. Thind K, Padrnos LJ, Ramanathan RK, Borad MJ. Immunotherapy in pancreatic cancer treatment: a new frontier. Therap Adv Gastroenterol. 2017 Jan; 10 (1):168-194 Epub 2016 Oct 17
    View PubMed
  23. Padrnos L, Karlin N, Halfdanarson TR. Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012. Rare Tumors. 2016 Nov 17; 8 (4):6804
    View PubMed
  24. Padrnos LJ, Adamski J. Understanding laboratory test limitations can improve accuracy in diagnosing heparin induced thrombocytopenia. ASCP Case Report Transfusion Medicine Series. (accepted). 2016.
  25. Padrnos LJ, Barr PJ, Klassen CL, Fields HE, Azadeh N, Mendoza N, Saadiq RA, Pauwels EM, King CS, Chung AA, Sakata KK, Blair JE. Introducing routine HIV screening for patients on an internal medicine residency inpatient service: a quality improvement project. BMJ Qual Improv Rep. 2016; 5 (1) Epub 2016 May 05
    View PubMed
  26. Padrnos L, Dueck AC, Scherber R, Glassley P, Stigge R, Northfelt D, Mikhael J, Aguirre A, Bennett RM, Mesa RA. Quality of life and disease understanding: impact of attending a patient-centered cancer symposium. Cancer Med. 2015 Jun; 4 (6):800-7 Epub 2015 Jan 30
    View PubMed
  27. Padrnos LJ, Blair JE, Kusne S, DiCaudo DJ, Mikhael JR. Cutaneous legionellosis: case report and review of the medical literature. Transpl Infect Dis. 2014 Apr; 16(2):307-14. Epub 2014 Mar 17.
    View PubMed
  28. Padrnos L, Mesa RA. A closer look at pacritinib: A JAK2/FLT3 inhibitor for the treatment of myelofibrosis. Expert Opinion on Orphan Drugs. 2014; 2(7):725-33.
  29. Padrnos L, Bui T, Pattee JJ, Whitmore EJ, Iqbal M, Lee S, Singarajah CU, Robbins RA. Analysis of overall level of evidence behind the Institute of Healthcare Improvement ventilator-associated pneumonia guidelines. Southwest J Pulm Crit Care. 2011 Aug 3; 3:40-8.